Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Feb 20;14(2):e0211812.
doi: 10.1371/journal.pone.0211812. eCollection 2019.

Significance of subepithelial deposits in patients diagnosed with IgA nephropathy

Affiliations
Clinical Trial

Significance of subepithelial deposits in patients diagnosed with IgA nephropathy

Mineaki Kitamura et al. PLoS One. .

Abstract

Subepithelial deposits are observed in rare adult IgA nephropathy (IgAN) cases and are a key diagnostic finding in IgA-dominant infection-related glomerulonephritis (IgA-IRGN). Sometimes, it is difficult to distinguish IgA-IRGN from IgAN without a precise clinical history. We hypothesized that some IgA-IRGN cases might be diagnosed as IgAN with subepithelial deposits (IgAN-SD) and aimed to clarify the significance of subepithelial deposits in patients diagnosed with IgAN. We examined 464 patients diagnosed with IgAN at Nagasaki University Hospital and affiliated hospitals between 1996 and 2013. The differences in clinicopathological findings between IgAN-SD and IgAN with no subepithelial deposits (IgAN-NSD) were investigated. In addition to clinical data and typical IgAN pathological features, we analyzed complement levels, immunoglobulin localization, light chain staining patterns, and intramembranous deposits. There were 214 men and 250 women with a mean age of 38.8 ± 18.3 years. Subepithelial deposition was observed in 51 patients (11%). Compared to patients with IgAN-NSD, those with IgAN-SD had significantly lower mean serum protein (6.4 g/dL vs. 6.7 g/dL; p = 0.02), albumin (3.7 g/dL vs. 3.9 g/dL; p = 0.02), and complement (C3) (94 mg/dL vs. 103 mg/dL; p = 0.02) levels. Diffuse mesangial hypercellularity (M) (65% vs. 45%; p<0.01), endocapillary hypercellularity: (E) (43% vs. 28%; p = 0.03), and IgA staining in the glomerular capillary wall (22% vs. 8%; p<0.01) were more common in patients with IgAN-SD. The incidence of light chain lambda predominance was lower in patients with IgAN-SD (47% vs. 63%; p = 0.03). Hump-shaped subepithelial deposits and intramembranous deposits were observed in nine and 17 patients with IgAN-SD, respectively. Patients with IgAN-SD tended to have the characteristics of IgA-IRGN rather than IgAN-NSD. Since the therapeutic strategies for IgA-IRGN differ from those for IgAN, we should review the clinical history and pay careful attention to the clinical course in cases with atypical findings, such as subepithelial deposits.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Representative immunofluorescence patterns of IgA and C3.
(A) IgA deposition and (B) C3 deposition in mesangial areas in a typical IgA nephropathy case. (C) IgA deposition and (D) C3 deposition in both mesangial and capillary areas in an atypical IgA nephropathy case. All magnifications of photos are x400.
Fig 2
Fig 2. Electron microscopic photograph of representative case of hump-shaped subepithelial deposits in IgAN-SD.
Case 7 in Table 2 upper side is shown.

Similar articles

Cited by

References

    1. Berger J. IgA glomerular deposits in renal disease. Transplant Proc. 1969;1: 939–944. - PubMed
    1. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368: 2402–2414. 10.1056/NEJMra1206793 - DOI - PubMed
    1. Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD Atlas of Renal Pathology: IgA nephropathy. Am J Kidney Dis. 2015;66: e33–34. 10.1053/j.ajkd.2015.08.001 - DOI - PubMed
    1. Yoshimura M, Kida H, Abe T, Takeda S, Katagiri M, Hattori N. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am J Kidney Dis. 1987;9: 404–409. - PubMed
    1. Lee HS, Choi Y, Lee JS, Yu BH, Koh HI. Ultrastructural changes in IgA nephropathy in relation to histologic and clinical data. Kidney Int. 1989;35: 880–886. - PubMed

Publication types

Substances